These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23870605)

  • 21. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
    Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
    Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic interaction between rosuvastatin and olmesartan: a randomized, open-label, 3-period, multiple-dose crossover study in healthy Korean male subjects.
    Roh H; Son H; Lee D; Chang H; Yun C; Park K
    Clin Ther; 2014 Aug; 36(8):1159-70. PubMed ID: 25017182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females.
    Chen X; Hu P; Jiang J; Liu T; Zhong W; Liu H; Zhao Q
    Clin Drug Investig; 2012 Dec; 32(12):783-90. PubMed ID: 23160920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers.
    Seong SJ; Ohk B; Kang WY; Gwon MR; Kim BK; Cho S; Yang DH; Lee HW; Yoon YR
    Adv Ther; 2019 Jul; 36(7):1642-1656. PubMed ID: 31119689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and bioequivalence study comparing a candesartan cilexetil/rosuvastatin calcium fixed-dose combination with the concomitant administration of candesartan cilexetil and rosuvastatin calcium in healthy Korean subjects
.
    Park DB; Jang K; Lee JW; Park CW; Lee BH; Kim MG; Jeon JY
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):286-294. PubMed ID: 28079517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic Interaction Between Rosuvastatin, Telmisartan, and Amlodipine in Healthy Male Korean Subjects: A Randomized, Open-label, Multiple-dose, 2-period Crossover Study.
    Son M; Guk J; Kim Y; Woo Chae D; Heo YA; Soh D; Park K
    Clin Ther; 2016 Aug; 38(8):1845-57. PubMed ID: 27422590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP
    Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic properties and bioequivalence of two sulfadoxine/pyrimethamine fixed-dose combination tablets: a parallel-design study in healthy Chinese male volunteers.
    Liu YM; Zhang KE; Liu Y; Zhang HC; Song YX; Pu HH; Lu C; Liu GY; Jia JY; Zheng QS; Zhu JM; Yu C
    Clin Ther; 2012 Nov; 34(11):2212-20. PubMed ID: 23084093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of single and multiple oral doses of valsartan/amlodipine (80/5 mg) in healthy Chinese subjects.
    Duan J; Chen J; Yin Q; Karan R; Meiser K; Smith HT; Sunkara G
    Int J Clin Pharmacol Ther; 2012 Jan; 50(1):33-43. PubMed ID: 22192643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioequivalence and Pharmacokinetics of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects.
    Hu C; Hu X; Wang C; Zhao Z; Gao D; Chen X; Zhou D; Huang Y; Li L; Zhang L
    Clin Drug Investig; 2018 Dec; 38(12):1145-1154. PubMed ID: 30232699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants.
    Kim JH; Song JH; Kim M; Hong JH; Sunwoo J; Jung JG
    Adv Ther; 2024 Jul; 41(7):2808-2825. PubMed ID: 38771476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
    Bhad P; Ayalasomayajula S; Karan R; Leon S; Riviere GJ; Sunkara G; Jarugula V
    J Clin Pharmacol; 2011 Jun; 51(6):933-42. PubMed ID: 20852001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers.
    Oh M; Park SE; Ghim JL; Choi YK; Shim EJ; Shin JG; Kim EY
    Drug Des Devel Ther; 2017; 11():3543-3550. PubMed ID: 29270003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy.
    Ke Y; Zhu D; Hong H; Zhu J; Wang R; Cardenas P; Zhang Y
    Curr Med Res Opin; 2010 Jul; 26(7):1705-13. PubMed ID: 20469975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability.
    Dennison TJ; Smith JC; Badhan RK; Mohammed AR
    Drug Des Devel Ther; 2017; 11():811-826. PubMed ID: 28352156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE; Scott LJ
    Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers.
    Jia JY; Zhang MQ; Liu YM; Liu Y; Liu GY; Li SJ; Lu C; Weng LP; Qi YL; Yu C
    Clin Ther; 2010 Jul; 32(7):1387-95. PubMed ID: 20678685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.